|
Volumn 38, Issue 2, 2011, Pages 177-178
|
A recombinant antimicrobial peptide inhibits the growth of oxacillin-induced l-forms of Staphylococcus aureus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPICILLIN;
CHLORAMPHENICOL;
HPAB BETA;
OXACILLIN;
POLYPEPTIDE ANTIBIOTIC AGENT;
UNCLASSIFIED DRUG;
VANCOMYCIN;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BACTERIAL GROWTH;
COMBINATION CHEMOTHERAPY;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG POTENTIATION;
IN VITRO STUDY;
LETTER;
MINIMUM INHIBITORY CONCENTRATION;
MONOTHERAPY;
NONHUMAN;
PRIORITY JOURNAL;
STAPHYLOCOCCUS AUREUS;
ANTI-BACTERIAL AGENTS;
ANTIMICROBIAL CATIONIC PEPTIDES;
BETA-DEFENSINS;
L FORMS;
MICROBIAL SENSITIVITY TESTS;
OXACILLIN;
RECOMBINANT PROTEINS;
STAPHYLOCOCCUS AUREUS;
|
EID: 79959771077
PISSN: 09248579
EISSN: 18727913
Source Type: Journal
DOI: 10.1016/j.ijantimicag.2011.02.015 Document Type: Letter |
Times cited : (2)
|
References (5)
|